While administration of MAR1-5A3 at day 2 after infection resulted in markedly enhanced viral burden in multiple tissues as seen in IFNAR-/- mice [8], treatment at day 4 had more subtle effects on viral replication. This evidence concerns the gene IFNAR1 and infection.